Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease.

MLA

Leng, Houfu, et al. “Modulating Glycosphingolipid Metabolism and Autophagy Improves Outcomes in Pre-Clinical Models of Myeloma Bone Disease.” Nature Communications, vol. 13, no. 1, Dec. 2022, pp. 1–18. EBSCOhost, https://doi.org/10.1038/s41467-022-35358-3.

APA

Leng, H., Zhang, H., Li, L., Zhang, S., Wang, Y., Chavda, S. J., Galas-Filipowicz, D., Lou, H., Ersek, A., Morris, E. V., Sezgin, E., Lee, Y.-H., Li, Y., Lechuga-Vieco, A. V., Tian, M., Mi, J.-Q., Yong, K., Zhong, Q., Edwards, C. M., & Simon, A. K. (2022). Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease. Nature Communications, 13(1), 1–18. https://doi.org/10.1038/s41467-022-35358-3

Chicago

Leng, Houfu, Hanlin Zhang, Linsen Li, Shuhao Zhang, Yanping Wang, Selina J. Chavda, Daria Galas-Filipowicz, et al. 2022. “Modulating Glycosphingolipid Metabolism and Autophagy Improves Outcomes in Pre-Clinical Models of Myeloma Bone Disease.” Nature Communications 13 (1): 1–18. doi:10.1038/s41467-022-35358-3.